SHP-2 ( PTPN11 ), a ubiquitously expressed protein tyrosine phosphatase, is critical for hematopoietic cell development and function owing to its essential role in growth factor/cytokine signaling. More importantly, germline and somatic mutations in this phosphatase are associated with Noonan syndrome, Leopard syndrome, and childhood hematologic malignancies. The molecular mechanisms by which SHP-2 mutations induce these diseases are not fully understood, as the biochemical bases of SHP-2 functions still remain elusive. Further understanding SHP-2 signaling activities and identification of its interacting proteins/substrates will shed light on the pathogenesis of PTPN11 -associated hematologic malignancies, which, in turn, may lead to novel therapeutics for these diseases.
CITATION STYLE
Liu, X., & Qu, C.-K. (2011). Protein Tyrosine Phosphatase SHP-2 ( PTPN11 ) in Hematopoiesis and Leukemogenesis. Journal of Signal Transduction, 2011, 1–8. https://doi.org/10.1155/2011/195239
Mendeley helps you to discover research relevant for your work.